Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results And New Data Reinforcing Strategic Focus In Kidney Disease
Stay updated with breaking news from Corporate Development Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
24.04.2024 - Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In-depth analysis of VIVIAD Phase 2b results is ongoing, including pre-specified and exploratory endpoints; findings to date ...
Wheaton Precious Metals Announces Record Revenue for the First Quarter of 2021 TSX | NYSE | LSE: WPM Designated News Release FIRST QUARTER 2021 FINANCIAL RESULTS “Wheaton’s first quarter results illustrate the strength and growth profile of our diversified, high-quality portfolio with record revenue achieved and over $230 million in operating cash flow generated. As a result of these strong results, we have increased our dividend for the third quarter in a row and now have net cash on the … TSX | NYSE | LSE: WPM FIRST QUARTER 2021 FINANCIAL RESULTS “Wheaton’s first quarter resul...